Free Trial

Ondine Biomedical (OBI) News Today

Ondine Biomedical logo
C$15.00 0.00 (0.00%)
As of 05:01 PM Eastern

OBI Latest News

Ondine Biomedical, Inc. (OBI) Receives a Buy from RBC Capital
Ondine Biomedical’s President Boosts Shareholding
Ondine Biomedical Inc Common Share
Ondine Recruits First Patient for US Phase 3 Trial
Ondine Commencing US Phase 3 Clinical Trial
Get Ondine Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OBI and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OBI Media Mentions By Week

OBI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OBI
News Sentiment

0.76

0.70

Average
Medical
News Sentiment

OBI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OBI Articles
This Week

1

1

OBI Articles
Average Week

Get the Latest News and Ratings for OBI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ondine Biomedical and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (LON:OBI) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners